01-04-2023 | Alopecia | News item
Non-serious case reports
Published in: Reactions Weekly | Issue 1/2023
Login to get accessExcerpt
The table below provides a list of the drugs associated with non-serious adverse events identified in the scientific literature over the last week.
Non-serious case reports
|
||
---|---|---|
Drug name(s)
|
Adverse event(s)
|
No. of cases
|
Adalimumab, Infliximab
|
Hypersensitivity, Oedema, Skin disorders
|
3
|
Alectinib
|
Diarrhoea
|
1
|
Alirocumab, Bempedoic acid, Evinacumab
|
Hyperlipoproteinaemia type IIa
|
1
|
Aminolevulinic acid
|
Pain
|
10
|
Aspirin, Dipyrone, Ibuprofen
|
Drug hypersensitivity
|
3
|
Atorvastatin, Dextran
|
Exanthema, Liver disorders, Nausea, Urticaria, Vomiting
|
4
|
AZD 1222
|
Haemorrhage, Headache, Skin disorders
|
12
|
BBIBP CorV
|
Injection site pain
|
1
|
BCG vaccine
|
Injection site reactions, Lymphadenopathy
|
3
|
Bisoprolol
|
Aphthous stomatitis
|
1
|
Bortezomib
|
Chalazion
|
1
|
Botulinum toxin
|
Skin disorders
|
1
|
Ceftriaxone
|
Hypersensitivity
|
1
|
Ciprofloxacin
|
Fatigue
|
1
|
Corticotropin
|
Headache, Hypertension
|
3
|
Elasomeran
|
Fever, Vomiting
|
1
|
Everolimus
|
Acne, Oral ulcer
|
1
|
Everolimus
|
Nausea, Stomatitis
|
1
|
Fluorouracil
|
Erythrodysaesthesia, Exanthema, Mucositis
|
3
|
Flutamide, Minoxidil, Spironolactone
|
Abdominal pain, Abnormal laboratory parameters, Hypertrichosis, Lethargy, Nausea
|
4
|
Fluticasone propionate
|
Epistaxis, Nose disorders
|
2
|
Ipilimumab
|
Alopecia
|
1
|
Ipilimumab
|
Diarrhoea, Fatigue
|
1
|
Iridium 192
|
Cystitis, Sexual function disorders
|
3
|
Methotrexate
|
Corneal injuries
|
1
|
Osimertinib
|
Diarrhoea, Exanthema
|
1
|
Osimertinib
|
Paronychia
|
1
|
Paclitaxel, Pertuzumab, Trastuzumab
|
Exanthema, Hypersensitivity
|
2
|
Paclitaxel, Toripalimab
|
Alopecia, Anorexia, Asthenia
|
1
|
Perampanel
|
Tinnitus
|
1
|
Plasma
|
Erythema, Hypotrichosis, Injection site
|
1
|
Selpercatinib
|
Fatigue, Headache
|
1
|
Sildenafil, Tadalafil
|
Headache, Lethargy, Nausea, Pain
|
2
|
Tenofovir alafenamide
|
Exanthema, Fatigue, Gastrointestinal disorders
|
3
|
Tocilizumab
|
Abnormal laboratory parameters, Thrombocytopenia
|
2
|
Tofacitinib
|
Anaemia, Elevated aminotransferase levels
|
2
|
Tofacitinib
|
Hypercholesterolaemia, Varicella zoster virus infections
|
2
|
Vedolizumab
|
Infusion related reaction
|
1
|